Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.550
-0.160 (-3.40%)
At close: Aug 13, 2025, 4:00 PM
4.230
-0.320 (-7.03%)
Pre-market: Aug 14, 2025, 8:57 AM EDT
Cryo-Cell International Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cryo-Cell International stock has a target of 8.50, which predicts a 86.81% increase from the current stock price of 4.55.
Price Target: $8.50 (+86.81%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Cryo-Cell International is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|
Strong Buy | 1 | 1 | 1 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Maintains $9 → $8.5 | Strong Buy | Maintains | $9 → $8.5 | +86.81% | Mar 4, 2025 |
Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +163.74% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
32.55M
from 31.99M
Increased by 1.75%
Revenue Next Year
32.53M
from 32.55M
Decreased by -0.05%
EPS This Year
-0.12
from 0.05
EPS Next Year
-0.05
from -0.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 33.5M | 33.5M |
Avg | 32.5M | 32.5M |
Low | 31.3M | 31.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | 4.7% | 2.9% |
Avg | 1.8% | -0.0% |
Low | -2.2% | -4.0% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.13 | -0.05 |
Avg | -0.12 | -0.05 |
Low | -0.12 | -0.05 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.